Standardization of Epidemiological Surveillance of Group A Streptococcal Pharyngitis
- PMID: 36128410
- PMCID: PMC9474939
- DOI: 10.1093/ofid/ofac251
Standardization of Epidemiological Surveillance of Group A Streptococcal Pharyngitis
Abstract
Pharyngitis, more commonly known as sore throat, is caused by viral and/or bacterial infections. Group A Streptococcus (Strep A) is the most common bacterial cause of pharyngitis. Strep A pharyngitis is an acute, self-limiting disease but if undertreated can lead to suppurative complications, nonsuppurative poststreptococcal immune-mediated diseases, and toxigenic presentations. We present a standardized surveillance protocol, including case definitions for pharyngitis and Strep A pharyngitis, as well as case classifications that can be used to differentiate between suspected, probable, and confirmed cases. We discuss the current tests used to detect Strep A among persons with pharyngitis, including throat culture and point-of-care tests. The type of surveillance methodology depends on the resources available and the objectives of surveillance. Active surveillance and laboratory confirmation is the preferred method for case detection. Participant eligibility, the surveillance population and additional considerations for surveillance of pharyngitis are addressed, including baseline sampling, community engagement, frequency of screening and season. Finally, we discuss the core elements of case report forms for pharyngitis and provide guidance for the recording of severity and pain associated with the course of an episode.
Keywords: Streptococcus pyogenes; epidemiology; infectious disease; pharyngitis; surveillance.
© The Author(s) 2022. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Conflict of interest statement
Potential conflicts of interest. All authors: No reported conflicts of interest. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.
References
-
- Carapetis JR, Steer AC, Mulholland EK, et al. . The global burden of group A streptococcal diseases. Lancet Infect Dis 2005; 5:685–94. - PubMed
-
- World Health Organization . WHO preferred product characteristics for group A Streptococcus vaccines. 2018. Available at: https://apps.who.int/iris/handle/10665/279142.
-
- Steer AC, Danchin MH, Carapetis JR. Group A streptococcal infections in children. J Paediatr Child Health 2007; 43:203–13. - PubMed
LinkOut - more resources
Full Text Sources
